There are many treatments now available for multiple myeloma. Quadruplet therapy, bispecific therapy, CAR T-cell therapy, and cereblon E3 ligase modulators (CELMoDs)…
Hope is my Superpower - a Column by Gina Diamante
One of my very first columns asked, “Where’s my secret decoder ring?” That was because it’s easy to become overwhelmed by the many names…
Remember my great plans to go walking regularly to combat chemo fog? “The best laid schemes o’ Mice an’ Men / Gang aft agley,” wrote…
I sometimes find inspiration for this column in surprising places. Tonight, I found it at the movie theater, during a showing of “Spider-Man:…
What do the San Diego Comic-Con and multiple myeloma have in common? Does that sound like a very strange question? Am I still stuck…
It’s the most wonderful time of the year! Some people have Christmas in July. Or the Fourth of July. I have nine days of fandom…
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
About 20 years ago, I worked seven days a week at two different jobs. My weekday job was an hour north of my home, while…
Recent Posts
- Infection risk shifts over time with both CAR T and bispecific antibody therapy
- Building the quiet architecture of a caregiving day
- New CAR T-cell therapy shows promise in tough myeloma cases
- CAR T-cell therapy before surgery boosts glioblastoma control in mice
- Gynecologic Cancer Awareness Month urges education, action, and support